cDNA microarray expression profile in vestibular schwannoma: correlation with clinical and radiological features

Cancer Genetics and Cytogenetics

Volumn 194, Issue 2, 2009, Pages 125-127

  Lassaletta, Luis ^a   Martínez Glez, Victor ^a   Torres Martín, Miguel ^a   Rey, Juan A ^a   Gavilán, Javier ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MTA1 PROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN BCL 2; PROTEIN FOS; PROTEIN MDM2; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; CLINICAL ARTICLE; DIZZINESS; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; HEARING LOSS; HUMAN; LETTER; MALE; MICROARRAY ANALYSIS; NEURILEMOMA; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; TUMOR VOLUME; VERTIGO; VESTIBULAR SCHWANNOMA;

ADOLESCENT; ADULT; AGED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; MALE; NEUROMA, ACOUSTIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLATELET-DERIVED GROWTH FACTOR; PROGNOSIS; REPRESSOR PROTEINS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 70349221423     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.06.016     Document Type: Letter

References (22)

1. Ahronowitz I., Xin W., Kiely R., Sims K., MacCollin M., and Nunes F.P. Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings. Hum Mutat 28 (2007) 1-12
2. Bello M.J., de Campos J.M., Kusak M.E., Vaquero J., Sarasa J.L., Pestaña A., and Rey J.A. Clonal chromosome aberrations in neurinomas. Genes Chromosomes Cancer 6 (1993) 206-211
3. Leone P.E., Bello M.J., Mendiola M., Kusak M.E., De Campos J.M., Vaquero J., Sarasa J.L., Pestaña A., and Rey J.A. Allelic status of 1p, 14q, and 22q and NF2 gene mutations in sporadic schwannomas. Int J Mol Med 1 (1998) 889-892
4. Warren C., James L.A., Ramsden R.T., Wallace A., Baser M.E., Varley J.M., and Evans D.G. Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation. J Med Genet 40 (2003) 802-806
5. Sandberg A.A., and Stone J.F. Benign peripheral nerve sheath tumors: neurofibromas, schwannomas, and perineuriomas. The genetics and molecular biology of neural tumors (2008), Humana Press, Totowa, NJ 1-41
6. Kino T., Takeshima H., Nakao M., Nishi T., Yamamoto K., Kimura T., Saito Y., Kochi M., Kuratsu J., Saya H., and Ushio Y. Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma. Genes Cells 6 (2001) 441-454
7. Gonzalez-Gomez P., Bello M.J., Alonso M.E., Lomas J., Arjona D., Campos J.M., Vaquero J., Isla A., Lassaletta L., Gutierrez M., Sarasa J.L., and Rey J.A. CpG island methylation in sporadic and neurofibromatis [ sic] type 2-associated schwannomas. Clin Cancer Res 9 (2003) 5601-5606
8. Bello M.J., Martinez-Glez V., Franco-Hernandez C., Pefla-Granero C., de Campos J.M., Isla A., Lassaletta L., Vaquero J., and Rey J.A. DNA methylation pattern in 16 tumor-related genes in schwannomas. Cancer Genet Cytogenet 172 (2007) 84-86
9. Lassaletta L., Bello M.J., Del Río L., Alfonso C., Roda J.M., Rey J.A., and Gavilan J.D.N.A. Methylation of multiple genes in vestibular schwannoma: relationship with clinical and radiological findings. Otol Neurotol 27 (2006) 1180-1185
10. Cheang M.C., van de Rijn M., and Nielsen T.O. Gene expression profiling of breast cancer. Annu Rev Pathol 3 (2008) 67-97
11. Ch G., Charalabopoulos A., Stagikas D., Giannakopoulos X., Peschos D., Batistatou A., Sofikitis N., and Charalabopoulos K. Molecular profiling and genomic microarrays in prostate cancer. Exp Oncol 29 (2007) 82-84
12. Welling D.B., Lasak J.M., Akhmametyeva E., Ghaheri B., and Chang L.S. cDNA microarray analysis of vestibular schwannomas. Otol Neurotol 23 (2002) 736-748
13. Hanemann C.O., Bartelt-Kirbach B., Diebold R., Kämpchen K., Langmesser S., and Utermark T. Differential gene expression between human schwannoma and control Schwann cells. Neuropathol Appl Neurobiol 32 (2006) 605-614
14. Seol H.J., Jung H.W., Park S.H., Hwang S.K., Kim D.G., Paek S.H., Chung Y.S., and Sub Lee C. Aggressive vestibular schwannomas showing postoperative rapid growth: their association with decreased p27 expression. J Neurooncol 75 (2005) 203-207
15. Martinez-Glez V., Franco-Hernandez C., Alvarez L., De Campos J.M., Isla A., Vaquero J., Lassaletta L., Cassartelli C., and Rey J.A. Meningiomas and schwannomas: molecular subgroup classification found by expression arrays. Int J Oncol 34 (2009) 493-504
16. Graamans K., Van Dijk J.E., and Janssen L.W. Hearing deterioration in patients with a non-growing vestibular schwannoma. Acta Otolaryngol 123 (2003) 51-54
17. Moon H.E., Cheon H., Chun K.H., Lee S.K., Kim Y.S., Jung B.K., Park J.A., Kim S.H., Jeong J.W., and Lee M.S. Metastasis-associated protein 1 enhances angiogenesis by stabilization of HIF-1α. Oncol Rep 16 (2006) 929-935
18. Miyake K., Yoshizumi T., Imura S., Sugimoto K., Batmunkh E., Kanemura H., Morine Y., and Shimada M. Expression of hypoxia-inducible factor-1α, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation. Pancreas 36 3 (2008) e1-e9
19. Manavathi B., Singh K., and Kumar R. MTA family of coregulators in nuclear receptor biology and pathology. Nucl Recept Signal 5 (2007) e010
20. Hofer M.D., Tapia C., Browne T.J., Mirlacher M., Sauter G., and Rubin M.A. Comprehensive analysis of the expression of the metastasis-associated gene 1 in human neoplastic tissue. Arch Pathol Lab Med 130 (2006) 989-996
21. Ostman A. PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine Growth Factor Rev 15 (2004) 275-286
22. Hoffmann A.C., Mori R., Vallbohmer D., Brabender J., Klein E., Drebber U., Baldus S.E., Cooc J., Azuma M., Metzger R., Hoelscher A.H., Danenberg K.D., Prenzel K.L., and Danenberg P.V. High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF. Neoplasia 10 (2008) 674-679